ESS vs OGEN · P/E 31, rev $1.89B vs rev $37.7K
Essex Property Trust Inc (ESS) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the ESS and OGEN stock pages for the full models.
Not investment advice.